Arcadia Biosciences (RKDA) Income towards Parent Company (2014 - 2026)

Arcadia Biosciences (RKDA) has 11 years of Income towards Parent Company data on file, last reported at -$27000.0 in Q4 2024.

• Quarterly Income towards Parent Company rose 98.76% year-over-year to -$27000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$27000.0 (up 99.45% YoY) and the FY2024 annual result came in at -$2.7 million, up 65.28% from the prior year.
• Income towards Parent Company grew to -$27000.0 in Q4 2024, from -$430000.0 in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $71.4 million in Q4 2021 to a low of -$9.9 million in Q2 2020.
• A 5-year average of $1.1 million and a median of -$1.8 million in 2021 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2021 — Income towards Parent Company jumped 727.56% — and 2024, when it plunged 715.47%.
• Tracing RKDA's Income towards Parent Company over 5 years: stood at $8.6 million in 2020, then soared by 727.56% to $71.4 million in 2021, then plunged by 101.61% to -$1.1 million in 2022, then tumbled by 89.11% to -$2.2 million in 2023, then surged by 98.76% to -$27000.0 in 2024.
• The last three Income towards Parent Company figures came in at -$27000.0 (Q4 2024), -$430000.0 (Q3 2024), and -$789000.0 (Q2 2024), per Business Quant data.